Deregulated c-fos modulates B cell responses to switch mediators. 1993

T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
Department of Immunology, ICMR, Kobe University School of Medicine, Japan.

We examined effects of deregulated c-fos on the proliferation and differentiation of B cells in vitro, using splenic B cells from H2-c-fos transgenic mice. When these cells were cultured with lipopolysaccharide (LPS) plus recombinant interleukin 4 (rIL-4) (10(4) U/ml), the proliferative response of the B cells was augmented with any dose of LPS used. This augmented proliferation resulted in an increase in IgG1 production in the culture, at the lower concentrations of LPS (< 2.5 micrograms/ml). However, H2-c-fos B cells did not produce IgG1 in the culture at higher concentrations of LPS (> 5 micrograms/ml) probably due to the perturbation of B cell differentiation to antibody-forming cells. These results suggest that the deregulated expression of c-fos modulates the proliferation and differentiation of B cells stimulated with LPS plus rIL-4.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
July 1993, Immunobiology,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
February 1993, Cancer letters,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
August 1995, Immunobiology,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
June 1995, Cancer letters,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
February 2010, The Journal of biological chemistry,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
January 1988, Cold Spring Harbor symposia on quantitative biology,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
October 1995, The Kobe journal of medical sciences,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
February 2017, Science (New York, N.Y.),
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
January 1987, Nature,
T Koizumi, and Y Ochi, and S Imoto, and N Sakai, and S Takao, and S Kobayashi, and M Matsuoka, and H Sakano, and U Rüther, and T Tokuhisa
February 2003, The Journal of biological chemistry,
Copied contents to your clipboard!